[2023.05] Absology signs listing sponsorship agreement with NH Investment & Securities > news

본문 바로가기
ABSOL VET Contact Us Login
  • · Korean
  • · English

Absology will be with you all the time.
With us, begin a new era of In-vitro Diagnosis.

[2023.05] Absology signs listing sponsorship agreement with NH Investm…



[Summary] Absolology's three main product lines are ABSOL, a susceptible in vitro immunodiagnostic platform based on various point-of-care diagnostics (POCT) that applies a microfluidics platform, ABSOL-HS, an ultra-sensitive diagnostic platform that can diagnose various heart diseases, degenerative, and traumatic brain diseases, and ABSOL-VET, an animal diagnostic device that can accurately diagnose diseases and measure chronic disease progression in companion animals.


Excerpt from medical observer